2014
DOI: 10.1016/j.procbio.2013.10.023
|View full text |Cite
|
Sign up to set email alerts
|

Biocatalytic production of 3′-sialyllactose by use of a modified sialidase with superior trans-sialidase activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
37
0
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 35 publications
(38 citation statements)
references
References 31 publications
0
37
0
1
Order By: Relevance
“…Considering that the global market for foods and beverages containing pre‐ and probiotics is estimated to be approximately US$ 15.4 billion and with dairy‐based foods and beverages constituting over half of this market, the potential for commercial production of human milk oligosaccharides and other prebiotic oligosaccharides is very appealing. Biosynthetic synthesis (analytical scale) of 3′‐sialyllactose and 6′‐sialyllactose, both considered as fundamental HMO structures with particular functions, has been achieved by using different types of one‐step enzymatic routes . In contrast, reports on the biocatalytic production of HMO backbone blueprint structures of LNT2 by using lactose and naturally occurring food‐grade oligosaccharides such as chitin derivatives as N ‐acetylglucosamine donors, and not p ‐nitrophenol‐modified β‐ N ‐acetylglucosamine or other unnatural saccharide derivatives as donor substrates, are scarce.…”
Section: Resultsmentioning
confidence: 99%
“…Considering that the global market for foods and beverages containing pre‐ and probiotics is estimated to be approximately US$ 15.4 billion and with dairy‐based foods and beverages constituting over half of this market, the potential for commercial production of human milk oligosaccharides and other prebiotic oligosaccharides is very appealing. Biosynthetic synthesis (analytical scale) of 3′‐sialyllactose and 6′‐sialyllactose, both considered as fundamental HMO structures with particular functions, has been achieved by using different types of one‐step enzymatic routes . In contrast, reports on the biocatalytic production of HMO backbone blueprint structures of LNT2 by using lactose and naturally occurring food‐grade oligosaccharides such as chitin derivatives as N ‐acetylglucosamine donors, and not p ‐nitrophenol‐modified β‐ N ‐acetylglucosamine or other unnatural saccharide derivatives as donor substrates, are scarce.…”
Section: Resultsmentioning
confidence: 99%
“…In trans-glycosylation reactions using glycosyl hydrolases, careful control of reaction time is often important due the inherent hydrolase activity that affects yield by degradation of both donor and product molecules [ 8 ]. It has also been demonstrated for other hydrolases that a high concentration of acceptor can improve transglycosylation yields [ 12 , 34 ]. We therefore set up reactions with a higher acceptor:donor ratio (100 mM lactose as acceptor and 25 mM pNP-Fuc as donor) and followed the reactions in time course-experiments.…”
Section: Resultsmentioning
confidence: 99%
“…Commercially sustainable processes for production of HMOs are therefore of great interest for both society and the dairy industry. 3 0 -sialyllactose (SL) is an HMO molecule which is currently produced from lactose and casein glyco macro peptide (cGMP) via an enzymatic reaction that relies on the presence of a large excess of lactose [2][3][4]. Once produced, the separation and purification of SL from lactose is a crucial step, as the SL added to the commercial formula should be as pure as possible.…”
Section: Introductionmentioning
confidence: 99%
“…Traditionally, when the production of SL has been performed at small scale, separation of lactose and SL has been achieved by anion exchange chromatography [5,4,3,2]. However, considering the economy of a large scale production process and the fact that anion exchange chromatography relies on the addition of buffers and eluents -which would then need to be removed before the SL can be considered for consumption -an alternative process for the efficient purification of SL from lactose is necessary for the addition of SL to infant formula to become a reality.…”
Section: Introductionmentioning
confidence: 99%